Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 281.72B | 281.72B | 245.12B | 211.91B | 198.27B | 168.09B |
Gross Profit | 193.89B | 193.89B | 171.01B | 146.05B | 135.62B | 115.86B |
EBITDA | 160.16B | 160.16B | 133.01B | 105.14B | 100.24B | 85.13B |
Net Income | 101.83B | 101.83B | 88.14B | 72.36B | 72.74B | 61.27B |
Balance Sheet | ||||||
Total Assets | 619.00B | 619.00B | 512.16B | 411.98B | 364.84B | 333.78B |
Cash, Cash Equivalents and Short-Term Investments | 94.56B | 94.56B | 75.53B | 111.26B | 104.75B | 130.26B |
Total Debt | 60.59B | 112.18B | 67.13B | 59.97B | 61.27B | 67.78B |
Total Liabilities | 275.52B | 275.52B | 243.69B | 205.75B | 198.30B | 191.79B |
Stockholders Equity | 343.48B | 343.48B | 268.48B | 206.22B | 166.54B | 141.99B |
Cash Flow | ||||||
Free Cash Flow | 71.61B | 71.61B | 74.07B | 59.48B | 65.15B | 56.12B |
Operating Cash Flow | 136.16B | 136.16B | 118.55B | 87.58B | 89.03B | 76.74B |
Investing Cash Flow | -72.60B | -72.60B | -96.97B | -22.68B | -30.31B | -27.58B |
Financing Cash Flow | -51.70B | -51.70B | -37.76B | -43.94B | -58.88B | -48.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | $3.73T | 36.97 | 33.28% | 0.66% | 14.93% | 15.50% | |
84 Outperform | $2.51T | 22.21 | 34.83% | 0.39% | 13.19% | 34.51% | |
82 Outperform | $150.55B | 22.70 | 52.25% | ― | 10.69% | 40.10% | |
81 Outperform | $2.44T | 34.90 | 24.77% | ― | 10.87% | 56.13% | |
80 Outperform | $3.40T | 34.53 | 149.81% | 0.44% | 5.97% | 0.15% | |
76 Outperform | $661.23B | 54.44 | 85.36% | 0.76% | 8.38% | 16.96% | |
54 Neutral | $298.66M | 3.86 | -5.40% | 2.71% | 9.11% | -73.63% |
Microsoft Corporation’s Board of Directors has amended the company’s Bylaws, effective July 1, 2025, to introduce a cure process for deficiencies in director nomination notices submitted by shareholders. This change allows shareholders to rectify any issues in their nomination notices within a specified time, potentially impacting shareholder engagement and governance practices.